Rate of Positive Family History in Iraqi Patients with Breast Cancer
DOI:
https://doi.org/10.22317/jcms.v11i1.1712Keywords:
Breast, cancer, family history, Iraqi patient.Abstract
Objective: The objective of this study was to understand the effect of positive family history as a risk factor between breast cancer patients depending on clinical and patiological features.
Methods: This is a clinical survey study contained 507 Iraqi breast cancer patients from July 2022 to May 2023. The assessment of patients performed using histopathological examination of tissue samples from breast biopsy or surgical excision. Family history interviews recorded. Participants were recruited from various healthcare facilities. The questionnaire covered age, residency, family history, metastasis, and the specific site of breast cancer. A signed informed consent process ensured patient confidentiality.
Results: This study examined the characteristics of breast cancer patients, including sex, age group, geographic distribution, and laterality. The sample consisted of 507 confirmed cases, 99.8% of which were females. Most patients were diagnosed on the left side, with 253 (49.9%) and 227 (44.77%) diagnosed on the right side. Unilateral breast cancer was predominant, with 53% of patients having bilateral breast cancer. Among the 507 patients, 31.76% had a positive family history of breast cancer, whereas 68% had a negative family history. Most patients had a first-degree relative to positive cancer, with 58 (36.02%) having a first-degree relative to positive cancer. The majority of cases did not show metastatic features, with the most metastatic cases being spread to the lymph nodes (6.7%).
Conclusion: The majority of breast cancer cases were left-sided, with 31.7% having a positive family history and 68% having a negative one. Most cases had a second-degree relative to a positive cancer history, with most cases spreading to the lymph nodes.
References
Sonalika S, Mishra S, Mahapatro S, Sahoo D. Advancements and Challenges in Breast Cancer: A Comprehensive Review. Med Res Arch. 2023;11(6).
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Vol. 95, British Journal of Radiology. 2022.
Madlool SA, Abdullah SS, Alabedi HH, Alazawy N, Al-Musawi MJ, Saad D, et al. Optimum Treatment Planning Technique Evaluation For Synchronous Bilateral Breast Cancer With Left Side Supraclavicular Lymph Nodes. Iranian Journal of Medical Physics [Internet]. 2020 Nov 9 [cited 2021 May 29];0. Available from: https://ijmp.mums.ac.ir/article_16970.html
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, et al. Risk factors and preventions of breast cancer. Vol. 13, International Journal of Biological Sciences. 2017.
Daly AA, Rolph R, Cutress RI, Copson ER. A review of modifiable risk factors in young women for the prevention of breast cancer. Vol. 13, Breast Cancer: Targets and Therapy. 2021.
Alabedi HH, Ahmed IK, Jamil ASM. Incidence of local breast cancer recurrence with delayed radiation therapy. Breast Cancer Res Treat. 2024 Jun;
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3).
Abdullah SS, Alabedi HH, Taha JH, Abdullah K. Treatment planning evaluation for bilateral breast cancer using volumetric modulated arc therapy (VMAT). Vol. 36, Revista de Senologia y Patologia Mamaria. 2023.
Iacoviello L, Bonaccio M, de Gaetano G, Donati MB. Epidemiology of breast cancer, a paradigm of the "common soil" hypothesis. Vol. 72, Seminars in Cancer Biology. 2021.
Alabedi H. Assessing setup errors and shifting margins for planning target volume in head, neck, and breast cancer. J Med Life. 2023;16(3).
Abdulbaqi AM, Abdullah SS, Alabedi HH, alazawy nabaa, Al-Musawi MJ, Heydar A faris. The effect of total fields' area and dose distribution in step and shoot IMRT on gamma passing rate using OCTAVIUS 4D-1500 detector phantom. Iranian Journal of Medical Physics [Internet]. 2020 Apr 26 [cited 2021 May 29];0. Available from: http://ijmp.mums.ac.ir/article_15518.html
Tabár L, Dean PB, Chen THH, Yen AMF, Chen SLS, Fann JCY, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019;125(4).
Mann RM, Hooley R, Barr RG, Moy L. Novel approaches to screening for breast cancer. Vol. 297, Radiology. 2020.
Haber G, Ahmed NU, Pekovic V. Family history of cancer and its association with breast cancer risk perception and repeat mammography. Am J Public Health. 2012;102(12).
Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, et al. Family history of breast cancer and its association with disease severity and mortality. Cancer Med. 2016;5(5).
Hemminki K, Granström C, Czene K. Attributable risks for familial breast cancer by proband status and morphology: A nationwide epidemiologic study from Sweden. Int J Cancer. 2002;100(2).
Alwan NAS. Breast Cancer Among Iraqi Women: Preliminary Findings From a Regional Comparative Breast Cancer Research Project. J Glob Oncol [Internet]. 2016 Mar 16;2(5):255–8. Available from: https://doi.org/10.1200/JGO.2015.003087
Hashim HT, Ramadhan MA, Theban KM, Bchara J, El-Abed-El-Rassoul A, Shah J. Assessment of breast cancer risk among Iraqi women in 2019. BMC Womens Health. 2021;21(1).
Alwan NAS. Family History among Iraqi Patients Diagnosed with Breast Cancer. International Journal of Science and Research (IJSR) [Internet]. 2017;6(2):869–73. Available from: https://www.ijsr.net/archive/v6i2/ART2017554.pdf%0Awww.ijsr.net
Tazzite A, Jouhadi H, Saiss K, Benider A, Nadifi S. Relationship Between Family History of Breast Cancer and Clinicopathological Features in Moroccan Patients. Ethiop J Health Sci [Internet]. 2013 [cited 2024 Aug 2];23(2):150. Available from:/pmc/articles/PMC3742892/
Ain Q, Richardson C, Mutebi M, George A, Kemp Z, Rusby JE. Does mainstream BRCA testing affect surgical decision-making in newly diagnosed breast cancer patients? Breast. 2023;67.
National Cancer Institute. BRCA Gene Mutations: Cancer Risk and Genetic Testing Fact Sheet - National Cancer Institute. National Cancer Institute. 2020.
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer Screening — Viewpoint of the IARC Working Group. New England Journal of Medicine. 2015;372(24).
Easton DF. Familial risks of breast cancer. Breast Cancer Research. 2002;4(5).
Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, et al. Risk factors for breast cancer in women: an update review. Vol. 39, Medical Oncology. 2022.
Zheng Y, Dong X, Li J, Qin C, Xu Y, Wang F, et al. Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China. JAMA Netw Open. 2022;5(11).
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
